Literature DB >> 12898225

Cloning and characterization of Taenia saginata paramyosin cDNA.

Elizabeth Ferrer1, Eva Moyano, Laura Benitez, Luis Miguel González, Denise Bryce, Mildred Foster-Cuevas, Iris Dávila, Maria Milagros Cortéz, Leslie J S Harrison, R Michael E Parkhouse, Teresa Gárate.   

Abstract

A lambdaZAP-express cDNA library of Taenia saginata metacestodes was constructed. Antibody screening yielded a clone with an insert of 3,408 bp, an open reading frame of 2,589 bp, a deduced sequence of 863 amino acid and a molecular mass of 98.89 kDa. Alignments of the predicted amino acid sequence showed identity with paramyosins from several species: 98.8% with Taenia solium, 96.3% with Echinococcus.granulosus and about 70% with Schistosoma spp. The insert was expressed and purified. A collagen binding assay was performed which showed that T. saginata GST-paramyosin retained this property in a dose-dependent manner. Problems were encountered due to high backgrounds in serological assays in the homologous T. saginata system. However, the recombinant paramyosin was recognized by antibodies present in 31.6% of sera from T. solium seropositive cysticercosis patients and 100% of the sera from acute cysticercosis patients. The immunodominant epitope was the carboxyl-terminal fragment of the molecule.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12898225     DOI: 10.1007/s00436-003-0895-5

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  35 in total

1.  Automated genome sequence analysis and annotation.

Authors:  M A Andrade; N P Brown; C Leroy; S Hoersch; A de Daruvar; C Reich; A Franchini; J Tamames; A Valencia; C Ouzounis; C Sander
Journal:  Bioinformatics       Date:  1999-05       Impact factor: 6.937

2.  Paramyosin inhibits complement C1.

Authors:  J P Laclette; C B Shoemaker; D Richter; L Arcos; N Pante; C Cohen; D Bing; A Nicholson-Weller
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

3.  cDNA cloning and recombinant expression of collagen-binding and complement inhibitor activity of Taenia solium paramyosin (AgB).

Authors:  A Landa; J P Laclette; A Nicholson-Weller; C B Shoemaker
Journal:  Mol Biochem Parasitol       Date:  1993-08       Impact factor: 1.759

4.  Observations on the hatching and activation of fresh Taenia saginata eggs.

Authors:  P Stevenson
Journal:  Ann Trop Med Parasitol       Date:  1983-08

5.  Characterization and protective potential of the immune response to Taenia solium paramyosin in a murine model of cysticercosis.

Authors:  J Vázquez-Talavera; C F Solís; L I Terrazas; J P Laclette
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

6.  A recombinant 10-kDa protein of Taenia solium metacestodes specific to active neurocysticercosis.

Authors:  J Y Chung; Y Y Bahk; S Huh; S Y Kang; Y Kong; S Y Cho
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

7.  Histological and ultrastructural localization of antigen B in the metacestode of Taenia solium.

Authors:  J P Laclette; M T Merchant; K Willms
Journal:  J Parasitol       Date:  1987-02       Impact factor: 1.276

8.  Paramyosin gene (unc-15) of Caenorhabditis elegans. Molecular cloning, nucleotide sequence and models for thick filament structure.

Authors:  H Kagawa; K Gengyo; A D McLachlan; S Brenner; J Karn
Journal:  J Mol Biol       Date:  1989-05-20       Impact factor: 5.469

9.  Human cysticercosis: antigens, antibodies and non-responders.

Authors:  A Flisser; E Woodhouse; C Larralde
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

10.  Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccine.

Authors:  E J Pearce; S L James; J Dalton; A Barrall; C Ramos; M Strand; A Sher
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

View more
  7 in total

1.  Ag-ELISA and PCR for monitoring the vaccination of cattle against Taenia saginata cysticercosis using an oncospheral adhesion protein (HP6) with surface and secreted localization.

Authors:  L J S Harrison; T Garate; D M Bryce; L M Gonzalez; M Foster-Cuevas; L W Wamae; J A Onyango-Abuje; R M E Parkhouse
Journal:  Trop Anim Health Prod       Date:  2005-02       Impact factor: 1.559

2.  Molecular cloning and characterization of a paramyosin from Clonorchis sinensis.

Authors:  Tae-Joon Park; Jung-Mi Kang; Byoung-Kuk Na; Woon-Mok Sohn
Journal:  Korean J Parasitol       Date:  2009-12-01       Impact factor: 1.341

3.  New method to disaggregate and analyze single isolated helminthes cells using flow cytometry: proof of concept.

Authors:  Karen Nava-Castro; Romel Hernández-Bello; Saé Muñiz-Hernández; Galileo Escobedo; Jorge Morales-Montor
Journal:  J Biomed Biotechnol       Date:  2011-12-01

4.  Evaluation of immune protection induced by DNA vaccines from Haemaphysalis longicornis paramyosin in rabbits.

Authors:  Tian-Tian Zhang; Jin-Cheng Zhang; Xue-Jiao Cui; Jing-Jing Zheng; Ru Li; Fang Wang; Jing-Ze Liu; Yong-Hong Hu
Journal:  Parasit Vectors       Date:  2017-07-06       Impact factor: 3.876

5.  Mapping of the Complement C9 Binding Region on Clonorchis sinensis Paramyosin.

Authors:  Jung-Mi Kang; Hương Giang Lê; Tuấn Cường Võ; Won Gi Yoo; Woon-Mok Sohn; Byoung-Kuk Na
Journal:  Korean J Parasitol       Date:  2022-08-24       Impact factor: 1.776

6.  Screening and molecular cloning of a protective antigen from the midgut of Haemaphysalis longicornis.

Authors:  Yonghong Hu; Jincheng Zhang; Shujie Yang; Hui Wang; Hua Zeng; Tiantian Zhang; Jingze Liu
Journal:  Korean J Parasitol       Date:  2013-06-30       Impact factor: 1.341

7.  Monoclonal antibody targeting complement C9 binding domain of Trichinella spiralis paramyosin impairs the viability of Trichinella infective larvae in the presence of complement.

Authors:  Yuwan Hao; Xi Zhao; Jing Yang; Yuan Gu; Ran Sun; Xinping Zhu
Journal:  Parasit Vectors       Date:  2014-07-04       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.